Arbutus Biopharma ABUS
NASDAQ ABUS
$4.45 -0.11 (-2.41%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arbutus Biopharma (ABUS) Gains from Sales and Divestitures (2017 - 2023)

Updated

Arbutus Biopharma (ABUS) posted Gains from Sales and Divestitures of $674,000 for FY2025.

Analysis

Arbutus Biopharma (ABUS) Gains from Sales and Divestitures (2017 - 2023) Analysis & Trends

Since FY2014, Arbutus Biopharma has reported Gains from Sales and Divestitures for 7 years.

  • The FY2025 figure stands as the highest annual Gains from Sales and Divestitures in data going back to FY2014.
  • Business Quant data shows ABUS's Gains from Sales and Divestitures at $20,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Arbutus Biopharma 879.47 Mn 506.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 20,000.00
Dec 31, 2022 -20,000.00
Dec 31, 2019 -31,000.00
Jun 30, 2019 2,000.00
Mar 31, 2019 9,000.00
Sep 30, 2018 26,000.00
Dec 31, 2017 3,000.00
API Access

Arbutus Biopharma Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ABUS&period=max&api_key=YOUR_API_KEY